Crohn’s (20110232)

The purpose of the study is to find out more about a protien, AMG 181, in people with moderate to severe Crohn’s disease. This study will evaluate whether the protein prevents immune cells from migrating into the gut and worsening the inflammation there.

Register Today!

Trial Information

Start DateJanuary 2014
End DateJuly 2018
Trial Duration24-216 weeks
Number of Visits11+
Lead CRCMarija Bernstein

For additional information
on this trial contact: